ํTWST โข NASDAQ
add
ํธ์์คํธ ๋ฐ์ด์ค์ฌ์ด์ธ์ค
$42.94
์๊ฐ์ธ:(0.77%)-0.33
$42.61
๋ง๊ฐ๋จ:1์ 23์ผ, PM 8์ 0๋ถ 0์ด GMT-5 · USD · NASDAQ · ๋ฉด์ฑ
์กฐํญ
์ ์ผ ์ข
๊ฐ
$45.15
์ผ์ผ ๋ณ๋ํญ
$42.75 - $45.50
52์ฃผ ๋ณ๋ํญ
$23.30 - $55.33
์๊ฐ์ด์ก
26.31์ต USD
ํ๊ท ๊ฑฐ๋๋
122.46๋ง
์ฃผ๊ฐ์์ต๋ฅ
-
๋ฐฐ๋น์์ต๋ฅ
-
๊ธฐ๋ณธ ๊ฑฐ๋์
NASDAQ
๋ด์ค
์ฌ๋ฌด
์์ต๊ณ์ฐ์
์์ต
์์ด์ต
| (USD) | 2025๋ 9์info | ์ ๋ ๋๋น ๋ณ๋ |
|---|---|---|
์์ต | 9900.90๋ง | 16.88% |
์ด์๋น | 8077.10๋ง | 8.74% |
์์ด์ต | -2713.80๋ง | 21.69% |
์์ด์ต๋ฅ | -27.41 | 33.00% |
์ฃผ๋น ์์ต | -0.45 | 23.73% |
EBITDA | -2683.00๋ง | 16.12% |
์ ํจ ์ธ์จ | -0.96% | โ |
๋์ฐจ๋์กฐํ
์ด์์ฐ
์ด๋ถ์ฑ
| (USD) | 2025๋ 9์info | ์ ๋ ๋๋น ๋ณ๋ |
|---|---|---|
ํ๊ธ ๋ฐ ๋จ๊ธฐ ํฌ์ | 2.32์ต | -15.91% |
์ด์์ฐ | 6.42์ต | 4.48% |
์ด๋ถ์ฑ | 1.69์ต | 19.25% |
์ด์๊ธฐ์๋ณธ | 4.73์ต | โ |
๋ฐํ ์ฃผ์ | 6114.80๋ง | โ |
์ฃผ๊ฐ์์์ฐ๋น์จ | 5.79 | โ |
์ด์์ฐ์ด์ต๋ฅ | -11.64% | โ |
์๋ณธ์ด์ต๋ฅ | -13.19% | โ |
ํ๊ธ ํ๋ฆ
์ํ๊ธํ๋ฆ
| (USD) | 2025๋ 9์info | ์ ๋ ๋๋น ๋ณ๋ |
|---|---|---|
์์ด์ต | -2713.80๋ง | 21.69% |
์์
ํ๊ธ ํ๋ฆ | -1181.40๋ง | 22.89% |
ํฌ์ ํ๊ธ ํ๋ฆ | -1240.30๋ง | -865.21% |
์๊ธ ์กฐ๋ฌ ํ๊ธ ํ๋ฆ | 557.40๋ง | 53.68% |
์ํ๊ธํ๋ฆ | -1848.00๋ง | -43.20% |
์์ฌ ํ๊ธ ํ๋ฆ | -1458.78๋ง | -124.74% |
์ ๋ณด
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
์ค๋ฆฝ
2013
์น์ฌ์ดํธ
์ง์ ์
979